Filing Flows

Filing Flows › Viatris (VTRS) › Next earnings date

Viatris (VTRS) earnings: beat the estimate

Viatris (VTRS) reported on Nov 5, 2026 and beat the EPS estimate: $0.71 against $0.64 (+11.3%). Revenue was $3.7B for Q3 2026, -0.3% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+11.3% vs estimate
Beat rate100%

The last report

Viatris reported revenue of $3.7B for the third quarter 2026 (-0.3% Y/Y), net loss $325M: Brands $2.5B, Lipitor $452M, EpiPen® Auto-Injectors $156M, Lyrica ® $114M. How it makes money → · Every quarter →

Viatris: EPS against the estimate, last 5 reportsViatris: EPS against the estimate, last 5 reportsEstimateReported$0.62$0.67Nov 25$0.53$0.57Feb 26$0.50$0.59May 26$0.60$0.69Aug 26$0.64$0.71Nov 26
Latest (Nov 26): Estimate $0.64, Reported $0.71.
VTRS: the stock's move on each reportVTRS: the stock's move on each reportAug 6, 2026-6.9%May 7, 2026+7.6%Feb 26, 2026-7.2%Nov 6, 2025-5.9%

Viatris' latest quarter

Viatris, Q3 2026: revenue $3.7B (-0.3% year over year), operating margin 7.0%, net loss $325M, operating cash flow $899M. The chart follows the revenue to costs, profit and cash.

Questions

Did Viatris beat earnings?

Viatris (VTRS) reported on Nov 5, 2026 and beat the EPS estimate: $0.71 against $0.64 (+11.3%).

When does VTRS report earnings?

The next date is not set yet.

Does Viatris usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.